Binding of [3H]SCH 39166 to human post mortem brain tissue

Area of Science:

• Neuroscience
• Pharmacology
• Radioligand Binding Assays

Background:

• Dopamine D1 receptors are crucial targets in the central nervous system.
• Radioligands are essential tools for studying receptor distribution and pharmacology.
• SCH 39166 is a known dopamine D1 antagonist.

Purpose of the Study:

• To characterize the binding properties of tritium-labeled SCH 39166 in human post mortem brain tissue.
• To compare the binding profile of [3H]SCH 39166 with a reference ligand, [3H]SCH 23390.
• To investigate the specificity and distribution of dopamine D1 receptor binding sites.

Main Methods:

• In vitro binding assays using tritium-labeled SCH 39166 ([3H]SCH 39166).
• Autoradiography on human post mortem brain sections.
• Competition binding studies with various antagonists (SCH 23390, SCH 39166, flupentixol).

Main Results:

• [3H]SCH 39166 demonstrated specific binding in the caudate nucleus, putamen, cortical regions, cerebellum, and hippocampus.
• Binding patterns of [3H]SCH 39166 were similar to [3H]SCH 23390, particularly in the medial caudate nucleus.
• Competition studies indicated that while SCH 23390 partially inhibited [3H]SCH 39166 binding, excess SCH 39166 significantly reduced [3H]SCH 23390 binding.

Conclusions:

• [3H]SCH 39166 effectively labels dopamine D1 receptors in the human brain.
• [3H]SCH 39166 exhibits a distinct binding pattern compared to [3H]SCH 23390.
• The observed differences may be attributed to binding at additional, non-dopamine D1 receptor sites.